Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Korea United Pharm's inventories, raw materials & components for the quarter that ended in Jun. 2026 was ₩24,298 Mil.
Korea United Pharm's quarterly raw materials
increased
from Dec. 2025 (₩22,136 Mil) to Mar. 2026 (₩23,332 Mil) and
increased
from Mar. 2026 (₩23,332 Mil) to Jun. 2026 (₩24,298 Mil).
Korea United Pharm's annual raw materials
increased
from Dec. 2023 (₩17,899 Mil) to Dec. 2024 (₩23,618 Mil) but then
declined
from Dec. 2024 (₩23,618 Mil) to Dec. 2025 (₩22,136 Mil).
Korea United Pharm Inventories, Raw Materials & Components Historical Data
* Premium members only.
The historical data trend for Korea United Pharm's Inventories, Raw Materials & Components can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Korea United Pharm Inventories, Raw Materials & Components Chart
What does a Inventories, Raw Materials & Components of ₩24,298 Mil mean?
Korea United Pharm (XKRX:033270) has a Inventories, Raw Materials & Components of ₩24,298 Mil as of Jun. 2026. Raw materials are the components a company uses for its main products. View historical data on Korea United Pharm and its competitors.
Is Korea United Pharm's Inventories, Raw Materials & Components too high?
Korea United Pharm's current Inventories, Raw Materials & Components is ₩24,298 Mil. Overall, Korea United Pharm has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Korea United Pharm's Inventories, Raw Materials & Components compare to ZTS?
Korea United Pharm's Inventories, Raw Materials & Components of ₩24,298 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Korea United Pharm and its competitors. Korea United Pharm's current Inventories, Raw Materials & Components is ₩24,298 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Korea United Pharm stock overvalued right now?
Based on GuruFocus' analysis, Korea United Pharm (XKRX:033270) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩20,351.55, compared to a current price of ₩17,910.00 — trading 12% below its estimated fair value. The current Inventories, Raw Materials & Components is ₩24,298 Mil. Korea United Pharm's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Korea United Pharm (XKRX:033270), the current Inventories, Raw Materials & Components is ₩24,298 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Korea United Pharm (XKRX:033270) Overvalued in 2026?
Based on GuruFocus' analysis, Korea United Pharm stock appears to be undervalued.
The current stock price of ₩17,910.00 is trading 12% below its estimated GF Value™ of ₩20,351.55.
GuruFocus considers Korea United Pharm to be Modestly Undervalued.
Key valuation signals for XKRX:033270:
Inventories, Raw Materials & Components: ₩24,298 Mil
GF Value™: ₩20,351.55 vs. price of ₩17,910.00 (12% below fair value)
No single metric tells the full story. See the XKRX:033270 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Korea United Pharm Inc is a South Korea based company engages in the manufacture and distribution of pharmaceuticals and healthcare products. It offers incrementally modified drug, anti-cancer, prescription, and OTC products.
90GF Score
Get the complete analysis for XKRX:033270
Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:033270 has been successfully added to your 
